Dual Modality Treatment Solution for Dermatologists to be Featured at CalDerm 2024
Radiant™ Aura is a painless, non-surgical office-based radiation therapy treatment option for patients with non-melanoma skin cancers (NMSC) and keloid scarring
Xstrahl, a global leader in the delivery of superficial radiation therapy devices and preclinical radiation research systems, will demonstrate Radiant Aura at the 2024 CalDerm Fall Symposium, Sept 6-8 at Omni La Costa Resort & Spa in Carlsbad, CA from Sept. 6-8, 2024.
“We are pleased to feature Radiant Aura at this year’s CalDerm Fall Symposium. Radiant Aura is a painless non-surgical skin cancer treatment alternative available to support the delivery of office-based radiation therapy for patients with NMSC when surgery is not possible, contraindicated, or simply not preferred due to cosmetic concerns,” said Adrian Treverton, CEO of Xstrahl.
Radiant Aura is a low-dose, X-ray based system, and is the only dual modality radiation therapy system that offers both non-invasive electronic brachytherapy (eBt) and superficial radiation therapy (SRT) for treating NMSC and keloid scarring.
To be placed on the VIP List for private events at the conference, please email kellywithers@xstrahl.com.
Visit Xstrahl at the 2024 CalDerm Fall Symposium in Carlsbad, CA from Sept. 6-8, 2024.
To learn more about Radiant Aura, visit https://xstrahl.com/calderm-2024/
To learn more about all Xstrahl clinical and research systems, visit www.xstrahl.com
About Xstrahl
Xstrahl is a medical technology company that designs radiation delivery devices to support clinical teams and cancer researchers. For more than 25 years, Xstrahl has been shaping the development of superficial and orthovoltage radiation therapy and advancing preclinical radiation research. Xstrahl systems are in operation at more than 700 treatment and research facilities worldwide.
